Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth

Cancer Biology and Therapy

Volumn 12, Issue 4, 2011, Pages 270-277

  Ueno, Yoshinori ^a   Sonoda, Shozo ^a   Suzuki, Ryo ^b   Yokouchi, Masahiro ^a   Kawasoe, Yasuomi ^a   Tachibana, Katsuro ^c   Maruyama, Kazuo ^b   Sakamoto, Taiji ^a   Komiya, Setsuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bubble liposome (BL); Cavitation; Doxorubicin; Drug delivery system (DDS); Osteosarcoma; Sonoporation; Ultrasound

Indexed keywords

BUBBLE LIPOSOME; DOXORUBICIN; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG SAFETY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY METASTASIS; LIVER METASTASIS; MONOTHERAPY; MOUSE; NONHUMAN; OSTEOSARCOMA; ULTRASOUND;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL PROLIFERATION; COMBINED MODALITY THERAPY; CONTRAST MEDIA; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; KAPLAN-MEIER ESTIMATE; LIPOSOMES; MICE; MICE, INBRED C3H; MICROBUBBLES; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; TIME FACTORS; TUMOR BURDEN; ULTRASONIC THERAPY;

EID: 84860402160     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.4.16259     Document Type: Article

References (43)

1. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999; 341:342-52; DOI: 10.1056/NEJM199907293410507.
2. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20:776-90; DOI: 10.1200/JCO.20.3.776.
3. Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004; 9:422-41; DOI: 10.1634/theoncologist.9-4-422.
4. Awada A, Piccart M. Strategies offering protection from the toxic effects of anticancer treatments with a focus on chemoprotective agents. Curr Opin Oncol 2000; 12:289-96; DOI: 10.1097/00001622-200007000-00003.
5. Meinardi MT, Gietema JA, van Veldhuisen DJ, van der Graaf WT, de Vries EG, Sleijfer DT. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev 2000; 26:429-47; DOI: 10.1053/ctrv.2000.0175.
6. Greenleaf WJ, Bolander ME, Sarkar G, Goldring MB, Greenleaf JF. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998; 24:587-95; DOI: 10.1016/S0301-5629(98) 00003-9.
7. Li T, Tachibana K, Kuroki M, Kuroki M. Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison and Levovist in mice-initial results. Radiology 2003; 229:423-8; DOI: 10.1148/radiol.2292020500.
8. Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, Unger RH, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101:2554-6.
9. Sonoda S, Tachibana K, Uchino E, Okubo A, Yamamoto M, Sakoda K, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci 2006; 47:558-64; DOI: 10.1167/iovs.05-0889.
10. Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002; 9:372-80; DOI: 10.1038/sj.gt.3301678.
11. Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105:1233-9; DOI: 10.1161/hc1002.105228.
12. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004; 3:527-32; DOI: 10.1038/nrd1417.
13. Harata M, Soda Y, Tani K, Ooi J, Takizawa T, Chen M, et al. CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells. Blood 2004; 104:1442-9; DOI: 10.1182/blood-2004-02-0588.
14. Kawamura K, Kadowaki N, Suzuki R, Udagawa S, Kasaoka S, Utoguchi N, et al. Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity. J Immunother 2006; 29:165-74; DOI: 10.1097/01.cji.0000190169.61416.f5.
15. Kogure K, Moriguchi R, Sasaki K, Ueno M, Futaki S, Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J Control Release 2004; 98:317-23; DOI: 10.1016/j.jconrel.2004.04.024.
16. Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, et al. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Release 2004; 98:195-207; DOI: 10.1016/j.jconrel.2004.04.018.
17. Mizoue T, Horibe T, Maruyama K, Takizawa T, Iwatsuru M, Kono K, et al. Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells. Int J Pharm 2002; 237:129-37; DOI: 10.1016/S0378-5173(02)00044-3.
18. Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoguchi N, et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm 2008; 346:143-50; DOI: 10.1016/j.ijpharm.2007.06.010.
19. Suzuki R, Takizawa T, Negishi Y, Hagisawa K, Tanaka K, Sawamura K, et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release 2007; 117:130-6; DOI: 10.1016/j.jconrel.2006. 09.008.
20. Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Sawamura K, Tanaka K, et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008; 125:137-44; DOI: 10.1016/j.jconrel.2007.08.025.
21. Suzuki R, Oda Y, Utoguchi N, Namai E, Taira Y, Okada N, et al. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J Control Release 2009; 133:198-205.
22. Negishi Y, Endo Y, Fukuyama T, Suzuki R, Takizawa T, Omata D, et al. Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound. J Control Release 2008; 132:124-30; DOI: 10.1016/j.jconrel.2008.08.019.
23. Negishi Y, Omata D, Iijima H, Takabayashi Y, Suzuki K, Endo Y, et al. Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound. Mol Pharm 2010; 7:217-26; DOI: 10.1021/mp900214s.
24. Suzuki R, Namai E, Oda Y, Nishiie N, Otake S, Koshima R, et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 2010; 142:245-50; DOI: 10.1016/j.jconrel.2009.10.027.
25. Allen TM, Hansen C, Martin F, Redemann C, Yau- Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066:29-36; DOI: 10.1016/0005-2736(91)90246-5.
26. Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1990; 1029:91-7; DOI: 10.1016/0005-2736(90)90440-Y.
27. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990; 268:235-7; DOI: 10.1016/0014-5793(90)81016-H.
28. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46:6387-92.
29. Muggia FM. Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention. Clin Cancer Res 1999; 5:7-8.
30. Hoving S, Seynhaeve AL, van Tiel ST, Eggermont AM, ten Hagen TL. Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing rats. Anticancer Drugs 2005; 16:667-74; DOI: 10.1097/00001813-200507000-00012.
31. Nobuto H, Sugita T, Kubo T, Shimose S, Yasunaga Y, Murakami T, et al. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int J Cancer 2004; 109:627-35; DOI: 10.1002/ijc.20035.
32. Shimose S, Sugita T, Nitta Y, Kubo T, Ikuta Y, Murakami T. Effect of thermosensitive liposomal doxorubicin with hyperthermia on primary tumor and lung metastases in hamster osteosarcoma. Int J Oncol 2001; 19:585-9.
33. Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 2001; 19:3312-22.
34. Sonoda S, Tachibana K, Uchino E, Yamashita T, Sakoda K, Sonoda KH, et al. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 2007; 6:1276-83; DOI: 10.4161/cbt.6.8.4485.
35. Kinoshita M, Hynynen K. A novel method for the intracellular delivery of siRNA using microbubbleenhanced focused ultrasound. Biochem Biophys Res Commun 2005; 335:393-9; DOI: 10.1016/j.bbrc.2005.07.101.
36. Kinoshita M, Hynynen K. Intracellular delivery of Bak BH3 peptide by microbubble-enhanced ultrasound. Pharm Res 2005; 22:716-20; DOI: 10.1007/s11095-005-2586-7.
37. Yamashita T, Sonoda S, Suzuki R, Arimura N, Tachibana K, Maruyama K, et al. A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo. Exp Eye Res 2007; 85:741-8; DOI: 10.1016/j.exer.2007.08.006.
38. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351:2170-8; DOI: 10.1056/NEJMoa041175.
39. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37:425-9; DOI: 10.1161/01.STR.0000199064. 94588.39.
40. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57:769-74; DOI: 10.3171/jns.1982.57.6.0769.
41. Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S, et al. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 1998; 76:418-22; DOI: 10.1002/(SICI)1097-0215(19980504)76:3〈418::AID-IJC21〉3.0.CO;2-5.
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63; DOI: 10.1016/0022-1759(83)90303-4.
43. Martin F, Caignard A, Jeannin JF, Leclerc A, Martin M. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer 1983; 2:623-7; DOI: 10.1002/ijc.2910320517.